Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage.
about
Phosphorylation of ErbB4 on tyrosine 1056 is critical for ErbB4 coupling to inhibition of colony formation by human mammary cell linesStructure, evolution, and biology of the MUC4 mucinNeuregulin3 alters cell fate in the epidermis and mammary glandStudies of ligand-induced site-specific phosphorylation of epidermal growth factor receptor.Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growthHerstatin, an autoinhibitor of the human epidermal growth factor receptor 2 tyrosine kinase, modulates epidermal growth factor signaling pathways resulting in growth arrest.Antibodies and Tyrosine Kinase Inhibitors in Breast Cancer Therapies.Cardiac-specific over-expression of epidermal growth factor receptor 2 (ErbB2) induces pro-survival pathways and hypertrophic cardiomyopathy in mice.Epidermal growth factor receptor mutations and susceptibility to targeted therapy in lung cancer.Cross signaling, cell specificity, and physiology.Expression of the EGF family in gastric cancer: downregulation of HER4 and its activating ligand NRG4.Autocrine epidermal growth factor signaling stimulates directionally persistent mammary epithelial cell migrationPrediction of functional phosphorylation sites by incorporating evolutionary informationThe ERBB3 receptor in cancer and cancer gene therapyEffect of acute acid-base disturbances on ErbB1/2 tyrosine phosphorylation in rabbit renal proximal tubules.Hepatocyte growth factor-mediated renal epithelial branching morphogenesis is regulated by glypican-4 expression.Signalling between microvascular endothelium and cardiomyocytes through neuregulin.Downregulation of ErbB3 by Wnt3a contributes to wnt-induced osteoblast differentiation in mesenchymal cells.Predominance of activated EGFR higher-order oligomers on the cell surface.The epidermal growth factor receptor (EGFR)-S442F mutant displays increased affinity for neuregulin-2beta and agonist-independent coupling with downstream signalling events.Zinc finger transcription factors designed for bispecific coregulation of ErbB2 and ErbB3 receptors: insights into ErbB receptor biology.EGFR kinase possesses a broad specificity for ErbB phosphorylation sites, and ligand increases catalytic-centre activity without affecting substrate binding affinity.Colocalization of somatostatin receptors and epidermal growth factor receptors in breast cancer cells.A novel cross-talk between endothelin and ErbB receptors controlling glutamate transporter expression in astrocytes.Regulation of early Xenopus development by ErbB signaling.A comprehensive review of heregulins, HER3, and HER4 as potential therapeutic targets in cancer.EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics.A novel feedback mechanism by Ephrin-B1/B2 in T-cell activation involves a concentration-dependent switch from costimulation to inhibition.Cancer: A shocking protein complex.Cell-specific and developmental expression of phospholipase C-gamma and diacylglycerol in fetal lung.
P2860
Q24318725-1A2B6BC3-D8AB-4325-8606-C75DD08BE800Q24630985-12D27550-014A-45AC-8196-7D5F51405FB7Q24681926-AEF7F02C-A1FF-407F-A6A7-BC3AB645A341Q33188385-0340A575-B1DD-4BD0-BA79-5B0A5E81B126Q34025197-C11F2DAF-64D4-4947-9AE2-ED35131019E1Q34122281-11267396-4455-4CDB-80D0-9D1DF620274AQ34140167-4D2C5553-2F89-4C6C-8049-13881928C01CQ34388932-C52B49CF-FE2C-42FC-9C4F-2800C68C7E67Q34575299-221BD80C-3564-4787-BB54-DB647A2326DAQ34675896-39C68C9D-33C0-412E-ACB3-B3C54F5205CDQ35146683-CB413EC4-19E0-4B50-81CA-2138EF77B4BFQ36381376-5044C5C3-DD1D-4EDF-B405-B5963F0BB952Q36922913-9576B63B-B512-42CF-9172-661110F0AA92Q37135372-64B8A9C6-6311-4D89-9EBA-4DE307CF7FB9Q37440141-A4CE8B4F-D96F-4EDA-8209-24FD87079B91Q37515584-DB5C5E5F-BDE3-4D55-BED8-E21F9AF66BCFQ37707158-73C24947-3498-451D-B377-71B230E80EE3Q39406865-58944D31-ED54-4026-872C-33D0B0E5994DQ39927376-A6DC4285-A460-4F8E-9420-7FB135797620Q40323538-910E9D15-E580-436D-83C1-3FD5E45FE860Q40366552-F66A1625-F12C-4EB1-A3DA-595D63059472Q40678332-21220D9C-07C4-493A-9389-FA5AC31750C0Q41881505-AFB523F2-4620-4140-BECA-FDA1A22FCBC8Q42507533-702028ED-4C9F-490D-BD5A-85AA43B68D08Q43194010-9CF26D23-21E3-46FD-A4F3-213DD962CB6DQ47158524-54370CC1-A75F-4F29-BE69-F31AB8DD7F1BQ47680913-B8B2A897-DC41-49C9-9FF9-47131E81C17FQ47721941-C7F924E2-5F2D-4194-843A-B450BDAE6680Q51428813-7FD7F2C5-8783-4925-B7D6-CABFAF3F6328Q52110667-78C1C6E2-44BC-490F-8B1C-A68665F655B6
P2860
Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Ligand discrimination by ErbB ...... al phosphorylation site usage.
@ast
Ligand discrimination by ErbB ...... al phosphorylation site usage.
@en
Ligand discrimination by ErbB ...... al phosphorylation site usage.
@nl
type
label
Ligand discrimination by ErbB ...... al phosphorylation site usage.
@ast
Ligand discrimination by ErbB ...... al phosphorylation site usage.
@en
Ligand discrimination by ErbB ...... al phosphorylation site usage.
@nl
prefLabel
Ligand discrimination by ErbB ...... al phosphorylation site usage.
@ast
Ligand discrimination by ErbB ...... al phosphorylation site usage.
@en
Ligand discrimination by ErbB ...... al phosphorylation site usage.
@nl
P356
P1433
P1476
Ligand discrimination by ErbB ...... al phosphorylation site usage.
@en
P2093
Carraway KL 3rd
P2888
P304
P356
10.1038/SJ.ONC.1203913
P407
P577
2000-11-01T00:00:00Z
P6179
1024539774